Loading...

quantusFLM

A revolution in fetal lung maturity tests

quantusFLM

You simply need an ultrasound

Easy to use

Easy to integrate

Free Trial

quantusFLM

A revolution in Fetal Pulmonary Maturity tests

Reliable, Non-invasive, Fast

ARE YOU A DOCTOR?

¡20% DC!
PACK OF 10 TESTS
560€*
*Offer valid from 03/02/2020 to 03/31/2020 both inclusive. Not combinable with other promotions
  • Offer your patients the latest advances in fetal medicine.
¡20% DC!
ARE YOU A DOCTOR?
PACK OF 10 TESTS
560€*
*Offer valid from 03/02/2020 to 03/31/2020 both inclusive. Not combinable with other promotions
  • Offer your patients the latest advances in fetal medicine.

A Revolutionary Solution to an Unsolved Clinical Need

Neonatal Respiratory Morbidity remains as the leading problem in preterm babies despite prenatal and postnatal treatments. But current tests for the assessment of Fetal Lung Maturity (FLM) require an amniocentesis, which limits their practice due to the associated risks and discomfort.

quantusFLM is the First 100% Non-Invasive fetal lung maturity test based on the analysis of an image of the fetal lungs obtained by ultrasound. It brings the opportunity to avoid the need for using invasive technique to predict the risk of neonatal respiratory morbidity.

quantusFLM comes as an easy-to-use web application that allows you to upload ultrasoud images for automatic analysis and receive reliable results within minutes.

Learn More

60

Countries

700

Clinics

98
%

Positive Opinions

115
k

Happy Mothers

Pay Per Analysis. No License Fees. No Hidden Cost.

quantusFLM is available in a Software as a Service (Saas) mode through a simple and intuitive web application.

We offer 30 Day Free Trial without obligations.

Try now to see how you and your patients can benefit from quantusFLM.

Learn More

Each day, more successful stories are counting:

Barcelona
Spain
Barcelona
Spain
Querétaro
Mexico
Muar, Johor
Malasya
San José
Costa Rica
Barranquilla
Colombia
Barcelona
Spain
Sonora
Mexico

Published on January/2020

quantusFLM, best case of Artificial Intelligence based on images

38th Annual Conference JP Morgan
Healthcare

Published on December/2019

Award for the most promising innovation in Digital Medicine 2019 by quantusFLM

Transmural Biotech receives the most promising innovation award in Digital Medicine 2019 awarded by NODE.Health in New York.
Click here to read.

Published on February/2019

The multicentre study of quantusFLM in ‘Nature’

Evaluation of an improved tool for non-invasive prediction of neonatal respiratory morbidity based on fully automated fetal lung ultrasound analysis.
Click here to read.

Published on November/2018

The non-invasive test to determine the lung maturity of the fetus reduces the use of corticosteroids

The preliminary results of a multicenter study have confirmed the usefulness of the non-invasive test that allows the evaluation of the lung maturity of the fetus by means of ultrasound.
Click here to read.

Published on January/2018

Mexico participates in the international research on quantusFLM

Rogelio Cruz Martínez, associate researcher of the Neurodevelopment Research Unit of the Institute of Neurobiology of the National Autonomous University of Mexico (UNAM) and Head of Fetal Medicine and Surgery, collaborated in an international project whose objective is to determine the lung maturity of fetuses during pregnancy, in order to predict the risk of neonatal respiratory distress syndrome (SDRN).
Click here to read.

Published on 14/05/2015

A Clinical Study about quantusFLM® is now available in ISUOG´s official journal!

The clinical study about quantusFLM® is published in this April´s ISUOG official journal- Ultrasound in Obstetrics and Gynecology Journal – the leading peer-reviewed journal on imaging in the given field. You can read the abstract here or download our white paper here.

Published on 27/02/2015

Transmural Biotech to Partner with Fetal Medicine Barcelona to Showcase quantusFLM® on 5-day On-site Course held in Seva from 2nd of March

Fetal Medicine Barcelona will hold a 5-day on-site course specialized in different aspects of fetal medicine at Seva, a beautiful town in the north of Barcelona from 2nd of March. We are honored to participate in such an important event in the fetal medicine, which is due to draw more than 300 professionals from Spain, Europe and Latin America. Apart from showcasing quantusFLM®, we will also organize different scientific sessions chaired by our clinical partners.

Published on 19/02/2015

quantusFLM® Has Officially Entered Middle East Market

On Feb. 13, quantusFLM® made its debut in the MENA market at the 5th International Conference on Obstetrics, Feto-Maternal Medicine and Therapy organized by Fetal Medicine & Genetic Center, Dubai. The conference has drawn more than 200 participants and we received lots of positive feedback on our innovative technology and successfully expanded quantusFLM® user base to the local market.

Published on 15/01/2015

Biocat refers Transmural Biotech as Perfect Example of Combining Innovative Technology and Business Model for Fetal Clinical Practice

Biocat, a leading organization aiming to promote and develop life sciences industry in Catalunya, refers Transmural Biotech as a perfect example of combining innovative technology and business model for its first product, quantusFLM. For the full report, click here.